Sponsor: Dow Chemical Foundation
Citation: For focusing on the career development of scientists to deliver practical solutions to synthesize new chemical entities to treat patients with grievous illnesses.
Current position: executive director of process development, Amgen
Education: B.Sc., chemistry, pharmacology, University College Dublin; M.Sc., organic chemistry, University College Dublin; Ph.D., synthetic organic chemistry, Harvard University
Faul on what she hopes to accomplish in the next decade: “I hope to continue to advance the commercialization of new drugs to treat grievous illness, especially in the area of oncology. I have lost too many friends and family to cancer. As chemists and engineers, we will be challenged with designing novel, efficient, and scalable processes to bring these medicines from the lab to the factory, and ultimately into the hands of patients. Knowing that my work ultimately serves patients suffering from grievous illness motivates me to come to work every day.”
What her colleagues say:“Margaret has had a high-impact career that has led to taking over management responsibilities of increasing magnitude over the last 20 years. She continues to demonstrate excellence in executive leadership and management of highly trained scientific staff.”—Jerry Murry, Amgen
Please send announcements of awards to email@example.com.